Pannexin 1 is required for full activation of insulin-stimulated glucose uptake in adipocytes

Molecular Metabolism

Volumn 4, Issue 9, 2015, Pages 610-618

  Adamson, Samantha E ^a,b   Meher, Akshaya K ^a   Chiu, Yu hsin ^a   Sandilos, Joanna K ^a   Oberholtzer, Nathaniel P ^a   Walker, Natalie N ^a   Hargett, Stefan R ^c   Seaman, Scott A ^b,c   Peirce Cottler, Shayn M ^b,c   Isakson, Brant E ^a,b   McNamara, Coleen A ^a,b   Keller, Susanna R ^a   Harris, Thurl E ^a   Bayliss, Douglas A ^a   Leitinger, Norbert ^a,b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c University of Virginia   (United States)

Author keywords

Adipocyte; Extracellular ATP; Glucose uptake; Pannexin 1

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; MEMBRANE PROTEIN; PANNEXIN 1; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DISEASE EXACERBATION; ELECTROPHYSIOLOGY; ENERGY EXPENDITURE; ENZYME RELEASE; GENE DELETION; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; HETEROLOGOUS EXPRESSION; HOMA IR MEASUREMENT; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN ACTIVATION; INSULIN RESISTANCE; INSULIN RESPONSE; INTRAABDOMINAL FAT; KNOCKOUT MOUSE; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

MURINAE; MUS;

EID: 84940437375     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2015.06.009     Document Type: Article

References (59)

1. Samuel V.T., Shulman G.I. Mechanisms for insulin resistance: common threads and missing links. Cell 2012, 148:852-871.
2. Shepherd P.R., Kahn B.B. Glucose transporters and insulin action - implications for insulin resistance and diabetes mellitus. The New England Journal of Medicine 1999, 341:248-257.
3. Kather H. Purine accumulation in human fat cell suspensions. Evidence that human adipocytes release inosine and hypoxanthine rather than adenosine. The Journal of Biological Chemistry 1988, 263:8803-8809.
4. Turpin B.P., Duckworth W.C., Solomon S.S. Perifusion of isolated rat adipose cells. Modulation of lipolysis by adenosine. The Journal of Clinical Investigation 1977, 60:442-448.
5. Schwabe U., Ebert R., Erbler H.C. Adenosine release from isolated fat cells and its significance for the effects of hormones on cyclic 3',5'-AMP levels and lipolysis. Naunyn-Schmiedeberg's Archives of Pharmacology 1973, 276:133-148.
6. Dhalla A.K., Chisholm J.W., Reaven G.M., Belardinelli L. A1 adenosine receptor: role in diabetes and obesity. Handbook of Experimental Pharmacology 2009, 271-295.
7. Martin S.E., Bockman E.L. Adenosine regulates blood flow and glucose uptake in adipose tissue of dogs. The American Journal of Physiology 1986, 250:H1127-H1135.
8. Green A. Catecholamines inhibit insulin-stimulated glucose transport in adipocytes, in the presence of adenosine deaminase. FEBS Letters 1983, 152:261-264.
9. Schwabe U., Schonhofer P.S., Ebert R. Facilitation by adenosine of the action of insulin on the accumulation of adenosine 3':5'-monophosphate, lipolysis, and glucose oxidation in isolated fat cells. European Journal of Biochemistry/FEBS 1974, 46:537-545.
10. Martin S.E., Lenhard S.D., Schmarkey L.S., Offenbacher S., Odle B.M. Adenosine regulates coronary blood flow during increased work and decreased supply. The American Journal of Physiology 1993, 264:H1438-H1446.
11. Junger W.G. Immune cell regulation by autocrine purinergic signalling. Nature Reviews Immunology 2011, 11:201-212.
12. Lee S.C., Pappone P.A. Effects of P2 purinergic receptor stimulation in brown adipocytes. The American Journal of Physiology 1997, 273:C679-C686.
13. Chowdhury H.H., Grilc S., Zorec R. Correlated ATP-induced changes in membrane area and membrane conductance in single rat adipocytes. Annals of the New York Academy of Sciences 2005, 1048:281-286.
14. Lee S.C., Pappone P.A. Membrane responses to extracellular ATP in rat isolated white adipocytes. Pflugers Archiv: European Journal of Physiology 1997, 434:422-428.
15. Lee S.C., Pappone P.A. ATP can stimulate exocytosis in rat brown adipocytes without apparent increases in cytosolic Ca2+ or G protein activation. Biophysical Journal 1999, 76:2297-2306.
16. Chang K.J., Cuatrecasas P. Adenosine triphosphate-dependent inhibition of insulin-stimulated glucose transport in fat cells. Possible role of membrane phosphorylation. The Journal of Biological Chemistry 1974, 249:3170-3180.
17. Tamura S., Dubler R.E., Larner J. Stimulation of maximal intracellular insulin action on glycogen synthase by preincubation of adipocytes with adenosine 5'-triphosphate. The Journal of Biological Chemistry 1983, 258:719-724.
18. Schodel J., Weise I., Klinger R., Schmidt M. Stimulation of lipogenesis in rat adipocytes by ATP, a ligand for P2-receptors. Biochemical and Biophysical Research Communications 2004, 321:767-773.
19. Hashimoto N., Robinson F.W., Shibata Y., Flanagan J.E., Kono T. Diversity in the effects of extracellular ATP and adenosine on the cellular processing and physiologic actions of insulin in rat adipocytes. The Journal of Biological Chemistry 1987, 262:15026-15032.
20. Yu Z., Jin T. Extracellular high dosages of adenosine triphosphate induce inflammatory response and insulin resistance in rat adipocytes. Biochemical and Biophysical Research Communications 2010, 402:455-460.
21. Burnstock G. Purinergic signalling in endocrine organs. Purinergic Signalling 2014, 10:189-231.
22. Yelovitch S., Barr H.M., Camden J., Weisman G.A., Shai E., Varon D., Fischer B., et al. Identification of a promising drug candidate for the treatment of type 2 diabetes based on a P2Y(1) receptor agonist. Journal of Medicinal Chemistry 2012, 55:7623-7635.
23. Pacheco P.A., Ferreira L.G., Alves L.A., Faria R.X. Modulation of P2 receptors on pancreatic beta-cells by agonists and antagonists: a molecular target for type 2 diabetes treatment. Current Diabetes Reviews 2013, 9:228-236.
24. Piwkowska A., Rogacka D., Jankowski M., Angielski S. Metformin reduces NAD(P)H oxidase activity in mouse cultured podocytes through purinergic dependent mechanism by increasing extracellular ATP concentration. Acta Biochimica Polonica 2013, 60:607-612.
25. Sandilos J.K., Bayliss D.A. Physiological mechanisms for the modulation of pannexin 1 channel activity. The Journal of Physiology 2012, 590:6257-6266.
26. Billaud M., Sandilos J.K., Isakson B.E. Pannexin 1 in the regulation of vascular tone. Trends in Cardiovascular Medicine 2012, 22:68-72.
27. Sridharan M., Adderley S.P., Bowles E.A., Egan T.M., Stephenson A.H., Ellsworth M.L., et al. Pannexin 1 is the conduit for low oxygen tension-induced ATP release from human erythrocytes. American Journal of Physiology. Heart and Circulatory Physiology 2010, 299:H1146-H1152.
28. Chekeni F.B., Elliott M.R., Sandilos J.K., Walk S.F., Kinchen J.M., Lazarowski E.R., et al. Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis. Nature 2010, 467:863-867.
29. Penuela S., Gehi R., Laird D.W. The biochemistry and function of pannexin channels. Biochimica et Biophysica Acta 2013, 1828:15-22.
30. Billaud M., Lohman A.W., Straub A.C., Looft-Wilson R., Johnstone S.R., Araj C.A., et al. Pannexin1 regulates alpha1-adrenergic receptor-mediated vasoconstriction. Circulation Research 2011, 109:80-85.
31. Kienitz M.C., Bender K., Dermietzel R., Pott L., Zoidl G. Pannexin 1 constitutes the large conductance cation channel of cardiac myocytes. The Journal of Biological Chemistry 2011, 286:290-298.
32. Sandilos J.K., Chiu Y.H., Chekeni F.B., Armstrong A.J., Walk S.F., Ravichandran K.S., et al. Pannexin 1, an ATP release channel, is activated by caspase cleavage of its pore-associated C-terminal autoinhibitory region. The Journal of Biological Chemistry 2012, 287:11303-11311.
33. Dahl G., Qiu F., Wang J. The bizarre pharmacology of the ATP release channel pannexin1. Neuropharmacology 2013, 75:583-593.
34. Silverman W., Locovei S., Dahl G. Probenecid, a gout remedy, inhibits pannexin 1 channels. American Journal of Physiology. Cell Physiology 2008, 295:C761-C767.
35. Wang J., Jackson D.G., Dahl G. The food dye FD&C Blue No. 1 is a selective inhibitor of the ATP release channel Panx1. The Journal of General Physiology 2013, 141:649-656.
36. Poon I.K., Chiu Y.H., Armstrong A.J., Kinchen J.M., Juncadella I.J., Bayliss D.A., et al. Unexpected link between an antibiotic, pannexin channels and apoptosis. Nature 2014, 507:329-334.
37. Shepherd P.R., Gnudi L., Tozzo E., Yang H., Leach F., Kahn B.B. Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissue. The Journal of Biological Chemistry 1993, 268:22243-22246.
38. Mullins G.R., Wang L., Raje V., Sherwood S.G., Grande R.C., Boroda S., et al. Catecholamine-induced lipolysis causes mTOR complex dissociation and inhibits glucose uptake in adipocytes. Proceedings of the National Academy of Sciences of the United States of America 2014, 111:17450-17455.
39. Wang Z.V., Deng Y., Wang Q.A., Sun K., Scherer P.E. Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression. Endocrinology 2010, 151:2933-2939.
40. Ayala J.E., Samuel V.T., Morton G.J., Obici S., Croniger C.M., Shulman G.I., et al. Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice. Disease Models & Mechanisms 2010, 3:525-534.
41. Lansey M.N., Walker N.N., Hargett S.R., Stevens J.R., Keller S.R. Deletion of Rab GAP AS160 modifies glucose uptake and GLUT4 translocation in primary skeletal muscles and adipocytes and impairs glucose homeostasis. American Journal of Physiology. Endocrinology and Metabolism 2012, 303:E1273-E1286.
42. Lohman A.W., Billaud M., Straub A.C., Johnstone S.R., Best A.K., Lee M., et al. Expression of pannexin isoforms in the systemic murine arterial network. Journal of Vascular Research 2012, 49:405-416.
43. Lohman A.W., Weaver J.L., Billaud M., Sandilos J.K., Griffiths R., Straub A.C., et al. S-nitrosylation inhibits pannexin 1 channel function. The Journal of Biological Chemistry 2012, 287:39602-39612.
44. Ramos R.R., Swanson A.J., Bass J. Calreticulin and Hsp90 stabilize the human insulin receptor and promote its mobility in the endoplasmic reticulum. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:10470-10475.
45. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
46. Dufresne J., Cyr D.G. Regulation of the pannexin-1 promoter in the rat epididymis. Biology of Reproduction 2014 Dec, 91(6):143.
47. Qu Y., Misaghi S., Newton K., Gilmour L.L., Louie S., Cupp J.E., et al. Pannexin-1 is required for ATP release during apoptosis but not for inflammasome activation. Journal of Immunology 2011, 186:6553-6561.
48. Billaud M., Choi Y., Lohman A.W., Parpaite T., Butcher J.T., Mutchler S.M., et al. A molecular signature in the pannexin 1 intracellular loop confers channel activation by the α1 adrenoreceptor in smooth muscle cells. Science Signalling 2015, 8(364):ra17.
49. Lee Y.H., Nair S., Rousseau E., Allison D.B., Page G.P., Tataranni P.A., et al. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia 2005, 48:1776-1783.
50. 2, and the sulfonylurea drug glimepiride. Molecular Pharmacology 2008, 73:1513-1529.
51. Wharton J., Meshulam T., Vallega G., Pilch P. Dissociation of insulin receptor expression and signaling from caveolin-1 expression. The Journal of Biological Chemistry 2005 Apr 8, 280(14):13483-13486.
52. Amoroso F., Falzoni S., Adinolfi E., Ferrari D., Di Virgilio F. The P2X7 receptor is a key modulator of aerobic glycolysis. Cell Death & Disease 2012 Aug 16, 3:e370.
53. Zaslavsky A., Li S., Xu Y. Sphingosine-1-phosphate induces a PDGFR-dependent cell detachment via inhibiting beta1 integrin in HEK293 cells. FEBS Letters 2005 Jul 18, 579(18):3899-3906.
54. Ekim B., Magnuson B., Acosta-Jaquez H.A., Keller J.A., Feener E.P., Fingar D.C. mTOR kinase domain phosphorylation promotes mTORC1 signaling, cell growth, and cell cycle progression. Molecular and Cellular Biology 2011 Jul, 31(14):2787-2801.
55. Odegaard J.I., Chawla A. Mechanisms of macrophage activation in obesity-induced insulin resistance. Nature Clinical Practice. Endocrinology & Metabolism 2008, 4:619-626.
56. Sun S., Ji Y., Kersten S., Qi L. Mechanisms of inflammatory responses in obese adipose tissue. Annual Review of Nutrition 2012, 32:261-286.
57. Elliott M.R., Chekeni F.B., Trampont P.C., Lazarowski E.R., Kadl A., Walk S.F., et al. Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance. Nature 2009, 461:282-286.
58. Adamson S.E., Leitinger N. The role of pannexin1 in the induction and resolution of inflammation. FEBS Letters 2014, 588:1416-1422.
59. Sun S., Xia S., Ji Y., Kersten S., Qi L. The ATP-P2X7 signaling axis is dispensable for obesity-associated inflammasome activation in adipose tissue. Diabetes 2012, 61:1471-1478.